Compare ABEV & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABEV | WAT |
|---|---|---|
| Founded | 1885 | 1958 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Staples | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.2B | 42.2B |
| IPO Year | 2012 | 1996 |
| Metric | ABEV | WAT |
|---|---|---|
| Price | $3.32 | $454.32 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 24 |
| Target Price | $3.35 | ★ $464.30 |
| AVG Volume (30 Days) | ★ 20.9M | 717.0K |
| Earning Date | 10-29-2026 | 11-03-2026 |
| Dividend Yield | ★ 3.68% | N/A |
| EPS Growth | N/A | ★ 0.47 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.60 | $103.98 |
| Revenue Next Year | $4.89 | $10.44 |
| P/E Ratio | $16.99 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.18 | $282.77 |
| 52 Week High | $3.45 | $465.36 |
| Indicator | ABEV | WAT |
|---|---|---|
| Relative Strength Index (RSI) | 65.77 | 62.48 |
| Support Level | $3.02 | $419.81 |
| Resistance Level | $3.33 | $454.54 |
| Average True Range (ATR) | 0.07 | 14.32 |
| MACD | 0.01 | 1.34 |
| Stochastic Oscillator | 86.36 | 71.79 |
Ambev is the largest brewer in Latin America and the Caribbean and is Anheuser-Busch InBev's subsidiary in the region. It produces, distributes, and sells beer and PepsiCo products in Brazil and other Latin American countries and owns Argentina's largest brewer, Quinsa. Ambev was formed in 1999 through the merger of Brazil's two largest beverage companies, Brahma and Antarctica. In 2004, Ambev combined with Canadian brewer Labatt, giving AB InBev a controlling interest of 62%.
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with Becton Dickinson's life science and diagnostics business, which increased its concentration in diagnostics and discovery-related life science tools.